-
-
-
-
-
-
-
Agios Pharma (AGIO) Announces Phase 3 ACTIVATE-T Trial of Mitapivat Achieved Primary Endpoint in Adults with PK Deficiency Who Are Regularly Transfused
-
-
-
-
-
-
-
Form 4 AGIOS PHARMACEUTICALS For: Mar 05 Filed by: Biller Scott
-
-
-
-
-
-
-
Form 4 AGIOS PHARMACEUTICALS For: Jun 08 Filed by: Biller Scott
-
-
-
-
-
-
68,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

